This site is intended for Healthcare Professionals only.

‘Keep LFD test kits away from direct sunlight’


Share post:

The Pharmaceutical Services Negotiating Committee (PSNC) has reminded all community pharmacy contractors of the storage conditions for lateral flow device (LFD) test kits.

As the country predicts to see higher temperatures by the end of the week, the pharmacy negotiator has asked contractors participating in the NHS community pharmacy Covid-19 lateral flow device distribution service to keep the test kits away from direct sunlight and between 2-30°C to preserve the integrity of the swab.

The committee said on Monday (July 12): “If a contractor has concerns around how their stock of LFD test kits has been stored or encounters problems maintaining LFD test kits at the appropriate temperature as the warmer weather commences, they are advised to contact NHS Test and Trace for further advice.”

The community pharmacy Covid-19 lateral flow device distribution service aims to improve access to testing by making LFD test kits readily available at community pharmacies for asymptomatic people, to identify positive cases in the community and break the chain of transmission.

This service works alongside the existing NHS Test and Trace Covid-19 testing routes.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Food prices remain UK consumers’ top concern, FSA report finds

Consumers worried about food affordability were more likely to take food safety risks to save money The Food...

UK life sciences failing to reach its potential despite high R&D investment, new report reveals

Wes Streeting recently announced his plans to bolster the economy through the life sciences sector “The UK remains...

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise...

Multiple sclerosis: England approves new jab that cuts hospital treatment time by 90%

In addition to significantly reducing treatment time for patients, the new multiple sclerosis injection could also save time...